SAN FRANCISCO, CA—Longer-term follow-up from the PARTNER 3 trial shows that both surgery and TAVI continue to provide similar clinical outcomes in low-risk patients with symptomatic severe aortic ...
Background—In EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure), eplerenone significantly reduced major cardiovascular events versus placebo in 2737 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback